Heejae Lee1,2, Hee Jin Lee1, In Hye Song3, Won Seon Bang1,2, Sun-Hee Heo1,2, Gyungyub Gong4, In Ah Park4. 1. Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. 2. Asan Center for Cancer Genome Discovery - Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. 3. Department of Hospital Pathology, Seoul St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 4. Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea natz821@naver.com gygong@amc.seoul.kr.
Abstract
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) are prognostic markers in triple-negative breast cancer (TNBC). Our study analyzed the relationship between cluster of differentiation (CD)11c-positive dendritic cells (DCs) and TILs and TLSs to elucidate mechanisms of TIL influx. MATERIALS AND METHODS: Immunohistochemical staining for CD4, CD8, and CD11c in tissue microarrays from 681 patients with TNBC was performed. The proportions of TILs and TLSs were reviewed. Two additional TNBC gene expression datasets were used. RESULTS: CD11c expression showed a significantly positive correlation with the level of TILs and the number of CD4+ and CD8+ T-cells, as well as an abundance of TLSs. CD11C gene expression was also significantly correlated with expression of CD4, CD8, and genes related to TLSs in both datasets. CONCLUSION: We demonstrated a strong correlation of CD11c expression, which represents DCs, with TILs and TLSs in TNBC. Further investigation is warranted to identify therapeutic modalities that facilitate recruitment and activation of DCs. Copyright
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) are prognostic markers in triple-negative breast cancer (TNBC). Our study analyzed the relationship between cluster of differentiation (CD)11c-positive dendritic cells (DCs) and TILs and TLSs to elucidate mechanisms of TIL influx. MATERIALS AND METHODS: Immunohistochemical staining for CD4, CD8, and CD11c in tissue microarrays from 681 patients with TNBC was performed. The proportions of TILs and TLSs were reviewed. Two additional TNBC gene expression datasets were used. RESULTS:CD11c expression showed a significantly positive correlation with the level of TILs and the number of CD4+ and CD8+ T-cells, as well as an abundance of TLSs. CD11C gene expression was also significantly correlated with expression of CD4, CD8, and genes related to TLSs in both datasets. CONCLUSION: We demonstrated a strong correlation of CD11c expression, which represents DCs, with TILs and TLSs in TNBC. Further investigation is warranted to identify therapeutic modalities that facilitate recruitment and activation of DCs. Copyright
Authors: Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov Journal: Nat Biotechnol Date: 2008-02-17 Impact factor: 54.908
Authors: A Tesniere; T Panaretakis; O Kepp; L Apetoh; F Ghiringhelli; L Zitvogel; G Kroemer Journal: Cell Death Differ Date: 2007-11-16 Impact factor: 15.828
Authors: Maro H Sandel; Alisher R Dadabayev; Anand G Menon; Hans Morreau; Cornelis J M Melief; Rienk Offringa; Sjoerd H van der Burg; Connie M Janssen-van Rhijn; N Geeske Ensink; Rob A E M Tollenaar; Cornelis J H van de Velde; Peter J K Kuppen Journal: Clin Cancer Res Date: 2005-04-01 Impact factor: 12.531
Authors: Marc Beyer; Hongwei Wang; Nina Peters; Sandra Doths; Cordula Koerner-Rettberg; Peter J M Openshaw; Jürgen Schwarze Journal: Respir Res Date: 2005-07-12
Authors: Jonas Steenbrugge; Niels Vander Elst; Kristel Demeyere; Olivier De Wever; Niek N Sanders; Wim Van Den Broeck; Luc Dirix; Steven Van Laere; Evelyne Meyer Journal: Front Immunol Date: 2019-12-17 Impact factor: 7.561